EXPRESSION OF INTERLEUKIN-2 RECEPTORS IN NORMAL AND NEOPLASTIC T CELLS NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


EXPRESSION OF INTERLEUKIN-2 RECEPTORS IN NORMAL AND NEOPLASTIC T CELLS

Int J Immunotherapy; 3(3):171-5 1987. Unique Identifier : AIDSLINE ICDB/88646848
Greene WC; Metabolism Branch, NCI, Bethesda, MD 20892


Abstract: Antigen activation of T cells stimulates the de novo synthesis and secretion of interleukin-2 (IL-2 or T-cell growth factor) and the expression of high and low affinity IL-2 receptors. The interaction of IL-2 with its high affinity receptor stimulates cellular proliferation, producing an expansion of the antigen-reactive clonal T-cell population. The activation process culminates in the generation of specific effector cells mediating helper, suppressor, and cytotoxic T-cell functions. Study of the human IL-2 receptor has been aided by the identification of a monoclonal antireceptor antibody, termed anti-Tac. Deregulated IL-2 receptor expression in T cells infected with the human T lymphotropic virus types I and II (HTLV-I and HTLV-II) has been detected. Salient features of IL-2 receptor expression in normal and neoplastic T cells are presented. The human IL-2 receptor (Tac) has been characterized at the protein, mRNA, and gene levels. The receptor protein is a glycosylated, sulfated, and phosphorylated 55,000-dalton transmembrane structure that contains a very short cytoplasmic tail. There are multiple IL-2 receptor (Tac) mRNAs within activated T cells. The protein sequence of the IL-2 receptor has been determined by analysis of a full-length IL-2 receptor cDNA. The receptor is composed of 272 amino acids, including a 21-residue signal peptide. The IL-2 receptor gene has been isolated and shown to be organized within 8 exons and 7 introns. In situ hybridization studies have localized this receptor gene to chromosome 10p band 14----15. Deregulated expression of IL-2 receptors has been detected in T-cell lines transformed with the oncogenic HTLV-I retrovirus. The constitutive expression of IL-2 receptors in adult T-cell leukemia (ATL) cell lines has been studied in considerable detail. ATL cell lines constitutively express large quantities of IL-2 receptor mRNA and each of the three known poly A addition sites are utilized. Cotransfection studies have demonstrated that the tat-I gene product is able to fully activate the human IL-2 receptor promoter and partially activate the human IL-2 promoter. These findings suggest the possibility that the tat-I-induced changes in these cellular genes that normally regulate T cell growth may play a role in HTLV-I-induced T-cell transformation. (33 Refs)
Keywords: Gene Expression Regulation Human HTLV-BLV Infections/*IMMUNOLOGY Leukemia/*IMMUNOLOGY Receptors, Immunologic/ANALYSIS/*GENETICS RNA, Messenger/ANALYSIS T-Lymphocytes/*IMMUNOLOGY JOURNAL ARTICLE

KWDgeneexpressionregulationhumanhtlv-blvinfections/KWDimmunologyleukemia/KWDimmunologyreceptors,immunologic/analysis/KWDgeneticsrna,messenger/analysist-lymphocytes/KWDimmunologyjournalarticle
880830
M8880542


Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .